Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07074015 · ClinicalTrials.gov registry record · NA
IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Specimens
A NA study, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07074015 is a NA study that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT07074015, a NA study, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will help determine whether an AI-assisted microwell platform (IntelliWell) can identify rare sperm cells in testicular samples found to not have sperm by conventional analysis. Instead of discarding testicular tissue which was found to be non-sperm bearing by conventional analysis the testicular tissue will be processed using IntelliWell and, if sperm is found and verified by embryologists, it may be used for intracytoplasmic sperm injection (ICSI).
Interventions
- DEVICE Use of IntelliWell to identify and localize sperm for ICSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07074015
The ClinicalTrials.gov registry entry for NCT07074015 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of IntelliWell to identify and localize sperm for ICSI is the first listed.
NCT07074015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07074015 about?
NCT07074015 is a clinical study titled "IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Specimens". This study will help determine whether an AI-assisted microwell platform (IntelliWell) can identify rare sperm cells in testicular samples found to not have sperm by conventional analysis. Instead of discarding testicular tissue which was found to be non-sperm bearing by conventional analysis the te...
What is the current status of trial NCT07074015?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04-16. Estimated completion is 2027-12-01.
What interventions are being tested in trial NCT07074015?
The interventions under investigation include: Use of IntelliWell to identify and localize sperm for ICSI (DEVICE).
Who is sponsoring clinical trial NCT07074015?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.